The effect of metformin and myoinositol on metabolic outcomes in women with polycystic ovary syndrome: role of body mass and adiponectin in a randomized controlled trial
The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Purpose To compare the effects of insulin sensitizers metformin (MET) and myo-inositol (MI) on adiponectin levels and metabolic characteristics in women with polycystic ovary syndrome (PCOS) with respect to their body mass index (BMI).Methods In this open label, parallel randomized clinical trial, 66 women with PCOS (33 normal-weight and 33 overweight/obese) were randomized to either MI (4 g/day) or MET (1500 mg/day) for a period of 6 months. Serum concentration of adiponectin, hormonal and metabolic laboratory outcomes and clinical assessment of BMI, body composition and Ferriman-Gallwey score (FG score) were evaluated before and after treatment.Results After the 6-month intervention, comparison between MET and MI in time to treatment analysis showed no significant differences between the two treatments for all analyzed parameters. Only borderline significantly lower AUC glucose was found in the MET group in comparison to the MI group (p = 0.071). The main effect of treatment was shown for glucose concentration at 120 min OGTT (p = 0.032) and testosterone (p = 0.002). The main effect of time was shown for body mass (p = 0.004), waist circumference (p < 0.001), BMI (p = 0.003), body fat mass (p = 0.001), adiponectin (p = 0.020), fasting glucose (p = 0.001), testosterone (p = 0.015), SHBG (p = 0.013), 17OH progesterone (p = 0.008), LH (p = 0.004) and estradiol (p = 0.014).Conclusion Our study showed similar effects of MET and MI on BMI, body composition, hormonal profile, metabolism of glucose and insulin, and adiponectin level. The two insulin sensitizers, MET and MI, were useful in reducing BMI and improving body composition without significant differences between the two treatments in PCOS women.Trial registration ISRCTN13199265. Trial registration date: 14.04.2021. (ISRCTN Registry), retrospectively registered.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In meta-analysis for androgenicity, metformin was superior to MI for FG score in 2 trials (MD 2.42, Fig. 5A) (26, 53), while MI was superior to metformin for SHBG (MD 3.85, Fig. 5C, 2 studies) (26, 53), with no differences in total testosterone in 4 trials (Fig. 5B) (26, 41, 42, 51, 53).”
From Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines (2024) · cites this paper as [53]
In the citing paper
“In meta-analysis for androgenicity, metformin was superior to MI for FG score in 2 trials (MD 2.42, Fig. 5A) (26, 53), while MI was superior to metformin for SHBG (MD 3.85, Fig. 5C, 2 studies) (26, 53), with no differences in total testosterone in 4 trials (Fig. 5B) (26, 41, 42, 51, 53).”
From Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines (2024) · cites this paper as [53]
In the citing paper
“There were no differences between groups for metabolic, lipid, and most anthropometric outcomes including fasting glucose (Fig. 5D, 4 studies) (26, 41, 42, 51, 53), fasting insulin (Fig. 5E, 5 studies) (26, 30, 41, 42, 51, 53), HOMA-IR (Fig. 5F, 5 studies) (26, 33, 41, 42, 51, 53), total cholesterol, HDL, and LDL cholesterol (Fig. 5G–5I, 2 studies) (41, 42, 51), weight (Fig. 5J, 3 studies) (30, 41”
From Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines (2024) · cites this paper as [53]
In the citing paper
“In meta-analysis for androgenicity, metformin was superior to MI for FG score in 2 trials (MD 2.42, Fig. 5A) (26, 53), while MI was superior to metformin for SHBG (MD 3.85, Fig. 5C, 2 studies) (26, 53), with no differences in total testosterone in 4 trials (Fig. 5B) (26, 41, 42, 51, 53).”
From Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines (2024) · cites this paper as [53]
In the citing paper
“There were no differences between groups for metabolic, lipid, and most anthropometric outcomes including fasting glucose (Fig. 5D, 4 studies) (26, 41, 42, 51, 53), fasting insulin (Fig. 5E, 5 studies) (26, 30, 41, 42, 51, 53), HOMA-IR (Fig. 5F, 5 studies) (26, 33, 41, 42, 51, 53), total cholesterol, HDL, and LDL cholesterol (Fig. 5G–5I, 2 studies) (41, 42, 51), weight (Fig. 5J, 3 studies) (30, 41”
From Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines (2024) · cites this paper as [53]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J.-I., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0255 · Cited by 4,856
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
Witchel, S. F., Oberfield, S., Rosenfield, R. L., Codner, E., Bonny, A., Ibáñez, L., Pena, A., Horikawa, R., Gomez-Lobo, V., Joel, D., et al. (2015) · Hormone Research in Paediatrics · doi:10.1159/000375530 · Cited by 3,113
Tang, T., Lord, J. M., Norman, R. J., Yasmin, E., & Balen, A. H. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003053.pub5 · Cited by 698
The polycystic ovary syndrome: a position statement from the European Society of Endocrinology
Conway, G., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Franks, S., Gambineri, A., Kelestimur, F., Macut, D., Micic, D., Pasquali, R., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0253 · Cited by 676
Self-citationMoghetti, P., Castello, R., Negri, C., Tosi, F., Perrone, F., Caputo, M., Zanolin, E., & Muggeo, M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6293 · Cited by 660
Pasquali, R., Gambineri, A., Biscotti, D., Vicennati, V., Gagliardi, L., Colitta, D., Fiorini, S., Cognigni, G. E., Filicori, M., & Morselli-Labate, A. M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6738 · Cited by 635
Removal of Visceral Fat Prevents Insulin Resistance and Glucose Intolerance of Aging
Gabriely, I., Ma, X. H., Yang, X. M., Atzmon, G., Rajala, M. W., Berg, A. H., Scherer, P., Rossetti, L., & Barzilai, N. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2951 · Cited by 563
Escobar-Morreale, H. F., Carmina, E., Dewailly, D., Gambineri, A., Kelestimur, F., Moghetti, P., Pugeat, M., Qiao, J., Wijeyaratne, C. N., Witchel, S. F., et al. (2012) · Human Reproduction Update · doi:10.1093/humupd/dmr042 · Cited by 494
Nestler, J. E., & Jakubowicz, D. J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4431 · Cited by 368
Naderpoor, N., Shorakae, S., de Courten, B., Misso, M. L., Moran, L. J., & Teede, H. J. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmv025 · Cited by 334
Spritzer, P. M., Lecke, S. B., Satler, F., & Morsch, D. M. (2015) · Reproduction · doi:10.1530/rep-14-0435 · Cited by 330
Diamanti-Kandarakis, E., Kouli, C., Tsianateli, T., & Bergiele, A. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1380269 · Cited by 323
Morley, L. C., Tang, T., Yasmin, E., Norman, R. J., & Balen, A. H. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003053.pub6 · Cited by 296
Morin-Papunen, L. C., Koivunen, R. M., Ruokonen, A., & Martikainen, H. K. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00011-9 · Cited by 290
New markers of insulin resistance in polycystic ovary syndrome
Polak, K., Czyzyk, A., Simoncini, T., & Meczekalski, B. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0523-8 · Cited by 256
Naderpoor, N., Shorakae, S., de Courten, B., Misso, M. L., Moran, L. J., & Teede, H. J. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmv063 · Cited by 255
Diamanti-Kandarakis, E., Christakou, C. D., Kandaraki, E., & Economou, F. N. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0733 · Cited by 247
Adiponectin and resistin in PCOS: a clinical, biochemical and molecular genetic study
Escobar-Morreale, H. F. (2006) · Human Reproduction · doi:10.1093/humrep/del146 · Cited by 200
Inositols in Insulin Signaling and Glucose Metabolism
Bevilacqua, A., & Bizzarri, M. (2018) · International Journal of Endocrinology · doi:10.1155/2018/1968450 · Cited by 165
Panidis, D., Tziomalos, K., Misichronis, G., Papadakis, E., Betsas, G., Katsikis, I., & Macut, D. (2012) · Human Reproduction · doi:10.1093/humrep/der418 · Cited by 155
Artini, P. G., Di Berardino, O. M., Papini, F., Genazzani, A. D., Simi, G., Ruggiero, M., & Cela, V. (2013) · Gynecological Endocrinology · doi:10.3109/09513590.2012.743020 · Cited by 154
Altered D-Chiro-Inositol Urinary Clearance in Women With Polycystic Ovary Syndrome
Baillargeon, J.-P., Diamanti-Kandarakis, E., Ostlund, R. E., Apridonidze, T., Iuorno, M. J., & Nestler, J. E. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1070 · Cited by 146
Nestler, J. E., & Jakubowicz, D. J. (1998) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199805000-00018 · Cited by 135
Hirsch, A., Hahn, D., Kempná, P., Hofer, G., Nuoffer, J.-M., Mullis, P. E., & Flück, C. E. (2012) · Endocrinology · doi:10.1210/en.2012-1145 · Cited by 109
Reflections on inositol(s) for PCOS therapy: steps toward success
Nestler, J. E., & Unfer, V. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1054802 · Cited by 106
Adipocyte biology in polycystic ovary syndrome
Barber, T. M., & Franks, S. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.10.010 · Cited by 104
Croze, M. L., Vella, R., Pillon, N. J., Soula, H. A., Hadji, L., Guichardant, M., & Soulage, C. O. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.01.008 · Cited by 103
Effects of metformin on adrenal steroidogenesis in women with polycystic ovary syndrome
Marca, A. L., Morgante, G., Paglia, T., Ciotta, L., Cianci, A., & Leo, V. D. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00407-0 · Cited by 103
Lecke, S. B., Mattei, F. N., Morsch, D. M., & Spritzer, P. M. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.02.041 · Cited by 90
Trolle, B., Flyvbjerg, A., Kesmodel, U., & Lauszus, F. F. (2007) · Human Reproduction · doi:10.1093/humrep/dem271 · Cited by 90
Genazzani, A. D., Prati, A., Santagni, S., Ricchieri, F., Chierchia, E., Rattighieri, E., Campedelli, A., Simoncini, T., & Artini, P. G. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2012.685205 · Cited by 88
Echiburú, B., Pérez-Bravo, F., Galgani, J. E., Sandoval, D., Saldías, C., Crisosto, N., Maliqueo, M., & Sir-Petermann, T. (2018) · Steroids · doi:10.1016/j.steroids.2017.12.009 · Cited by 87
Antihyperglycemic mechanism of metformin occurs via the AMPK/LXRα/POMC pathway
Cho, K., Chung, J. Y., Cho, S. K., Shin, H.-W., Jang, I.-J., Park, J.-W., Yu, K.-S., & Cho, J.-Y. (2015) · Scientific Reports · doi:10.1038/srep08145 · Cited by 81
Olszanecka‐Glinianowicz, M., Kuglin, D., Dąbkowska-Huć, A., & Skałba, P. (2010) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2010.08.022 · Cited by 74
Vrbikova, J., Hill, M., Starka, L., Cibula, D., Bendlova, B., Vondra, K., Sulcova, J., & Snajderova, M. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1440619 · Cited by 71
Tan, B. K., Chen, J., Digby, J. E., Keay, S. D., Kennedy, C. R., & Randeva, H. S. (2006) · Diabetologia · doi:10.1007/s00125-006-0419-9 · Cited by 70
In vitro and in vivo Effects of Metformin on Human Adipose Tissue Adiponectin
Zulian, A., Cancello, R., Girola, A., Gilardini, L., Alberti, L., Croci, M., Micheletto, G., Danelli, P., & Invitti, C. (2011) · Obesity Facts · doi:10.1159/000324582 · Cited by 61
Romualdi, D., Giuliani, M., Cristello, F., Fulghesu, A. M., Selvaggi, L., Lanzone, A., & Guido, M. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.01.114 · Cited by 58
Pau, C. T., Keefe, C., Duran, J., & Welt, C. K. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4021 · Cited by 49
Metformin alters insulin signaling and viability of human granulosa cells
Sonntag, B., Götte, M., Wülfing, P., Schüring, A. N., Kiesel, L., & Greb, R. R. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.04.043 · Cited by 48
Januszewski, M., Issat, T., Jakimiuk, A. A., Santor-Zaczyńska, M., & Jakimiuk, A. J. (2019) · Ginekologia Polska · doi:10.5603/gp.2019.0002 · Cited by 47
Nascimento, A. D., Lara, L. A. S., Rosa-e-Silva, A. C. J. D. S., Ferriani, R. A., & Reis, R. M. (2013) · Gynecological Endocrinology · doi:10.3109/09513590.2012.736563 · Cited by 45
Sowers, M. R., Randolph, J. F., Jannausch, M. L., Lasley, B. L., Jackson, E. A., & McConnell, D. S. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.19.2146 · Cited by 43
Tagliaferri, V., Romualdi, D., Immediata, V., De Cicco, S., Di Florio, C., Lanzone, A., & Guido, M. (2017) · Clinical Endocrinology · doi:10.1111/cen.13304 · Cited by 40
Association of leptin and insulin resistance in PCOS: A case-controlled study
Namavar Jahromi, B., Infertility Research Center, S. U. O. M. S., Dabaghmanesh, M. H., Endocrine and Metabolism Research Center, S. U. O. M. S., Parsanezhad, M. E., Department of Obstetrics and Gynecology, S. O. M., Fatehpoor, F., & Student Research Committee, S. U. O. M. S. (2017) · International Journal of Reproductive BioMedicine · doi:10.29252/ijrm.15.7.423 · Cited by 40 · cited 1×
“5; and quantitative insulin sensitivity check index QUICKI [I/(log[fasting insulin (mU/l)] × log[fasting glucose (mg/dl)])] [22].”
Background(2019) · PubMed · doi:10.26355/eurrev_201903_17278 · Cited by 38
Macut, D., Bačević, M., Božić-Antić, I., Bjekić-Macut, J., Čivčić, M., Erceg, S., Vojnović Milutinović, D., Stanojlović, O., Andrić, Z., Kastratović-Kotlica, B., et al. (2015) · International Journal of Endocrinology · doi:10.1155/2015/812610 · Cited by 33
Self-citationThe Effect of Metformin on Glucose Homeostasis During Moderate Exercise
Hansen, M., Palsøe, M. K., Helge, J. W., & Dela, F. (2014) · Diabetes Care · doi:10.2337/dc14-1480 · Cited by 32
Gagnon, J., Sheppard, E., & Anini, Y. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12021 · Cited by 31
D’Anna, R., Santamaria, A., Cannata, M. L., Interdonato, M. L., Giorgianni, G. M., Granese, R., Corrado, F., & Bitto, A. (2014) · International Journal of Endocrinology · doi:10.1155/2014/653561 · Cited by 30
Prediction of the Effect of Metformin Treatment in Patients with Polycystic Ovary Syndrome
Vrbíková, J., Hill, M., Stárka, L., & Vondra, K. (2002) · Gynecologic and Obstetric Investigation · doi:10.1159/000053002 · Cited by 22
Sowers, M. R., Randolph, J. F., Jannausch, M. L., Lasley, B. L., Jackson, E. A., & McConnell, D. S. (2009) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000344396.06070.4f · Cited by 16
Karkanaki, A., Piouka, A., Katsikis, I., Farmakiotis, D., Μacut, D., & Panidis, D. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.06.034 · Cited by 15
Hamed, H. O. (2013) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.12101 · Cited by 12
Grigoryan, O. R., Absatarova, Y. S., En, A., Mel'nichenko, G. A., & Dedov, I. I. (2014) · PubMed · Cited by 10
Cited by
Greff, D., Juhász, A. E., Váncsa, S., Váradi, A., Sipos, Z., Szinte, J., Park, S., Hegyi, P., Nyirády, P., Ács, N., et al. (2023) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-023-01055-z · Cited by 143
“In the case of DHEAS and androstenedione, no significant difference was found.”
BackgroundInfluentialFitz, V., Graca, S., Mahalingaiah, S., Liu, J., Lai, L., Butt, A., Armour, M., Rao, V., Naidoo, D., Maunder, A., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad762 · Cited by 70
“5E, 5 studies) (26, 30, 41, 42, 51, 53), HOMA-IR (Fig.”
BackgroundInfluentialAdamczak, R., Ukleja-Sokołowska, N., Lis, K., & Dubiel, M. (2021) · Medicina · doi:10.3390/medicina57111251 · Cited by 71
Mladenović, D. R., Vesković, M. N., Šutulović, N., Hrnčić, D., Stanojlović, O. P., Radić, L., Macut, J. B., & Μacut, D. (2024) · Endocrine · doi:10.1007/s12020-024-03702-w · Cited by 37
Fiore, G., Pascuzzi, M. C., Profio, E. D., Corsello, A., Agostinelli, M., Mendola, A. L., Milanta, C., Campoy, C., Calcaterra, V., Zuccotti, G., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106599 · Cited by 33
Metadata
- Authors
- Soldat-Stanković, V., Popović-Pejičić, S., Stanković, S., Prtina, A., Malešević, G., Bjekić-Macut, J., Livadas, S., Ognjanović, S., Mastorakos, G., Micić, D., & Macut, D.
- Affiliations
- University of Banja Luka (BA)
- University of Belgrade (RS)
- Metropolitan Hospital (GR)
- National and Kapodistrian University of Athens (GR)
- Serbian Academy of Sciences and Arts (RS)
- Venue
- Journal of Endocrinological Investigation
- Published
- 2021-10-19
- Volume
- 45
- Issue
- 3
- Pages
- 583-595
- ISSN
- 0391-4097 (ISSN-L)
- 1720-8386
- OpenAlex
- W3205241365
- Cited by
- 37
- References
- 57
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 15 · 2023: 9 · 2022: 6 · 2021: 1
- FWCI
- 6.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Journal of Endocrinological Investigation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- polycystic ovary syndrome, metformin, myo-inositol, insulin sensitizers, adiponectin, body mass index, body composition, testosterone, insulin resistance, glucose metabolism, overweight and obesity, Ferriman-Gallwey score, sex hormone-binding globulin, luteinizing hormone, estradiol, 17-hydroxyprogesterone
- MeSH terms
- Adult, Blood Glucose, Body Composition, Female, Humans, Hypoglycemic Agents, Inositol, Insulin, Insulin Resistance, Metformin, Obesity, Polycystic Ovary Syndrome, Gonadal Steroid Hormones, Vitamin B Complex, Body Mass Index, Treatment Outcome, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.